Attention Deficit Drugs Part 1 PDF

Attention Deficit Drugs 1\. \*\*What is the primary goal of treating Attention Deficit Hyperactivity Disorder (ADHD)?\*\* \- A) Eliminate all hyperactivity \- B) Cure the disorder \- C) Reduce symptoms so the patient can function in all environments \- D) Improve only academic performance \*\*...

Attention Deficit Drugs 1\. \*\*What is the primary goal of treating Attention Deficit Hyperactivity Disorder (ADHD)?\*\* \- A) Eliminate all hyperactivity \- B) Cure the disorder \- C) Reduce symptoms so the patient can function in all environments \- D) Improve only academic performance \*\*Answer\*\*: C) Reduce symptoms so the patient can function in all environments 2\. \*\*Which of the following is considered first-line therapy for ADHD?\*\* \- A) Atomoxetine \- B) Stimulants \- C) Clonidine \- D) Guanfacine \*\*Answer\*\*: B) Stimulants 3\. \*\*Which type of ADHD diagnosis includes symptoms of inattention, hyperactivity, and impulsivity?\*\* \- A) ADHD predominantly inattentive \- B) ADHD combined \- C) ADHD predominantly hyperactive-impulsive \- D) ADHD in remission \*\*Answer\*\*: B) ADHD combined \#\#\# Slide 2 - ADHD Types 4\. \*\*What is a common symptom of ADHD in adults?\*\* \- A) Inattention \- B) Hyperactivity \- C) Aggression \- D) Anxiety \*\*Answer\*\*: A) Inattention 5\. \*\*Which ADHD subtype is characterized by difficulty focusing and sustaining attention without hyperactivity?\*\* \- A) ADHD predominantly inattentive \- B) ADHD predominantly hyperactive-impulsive \- C) ADHD combined \- D) ADHD in children \*\*Answer\*\*: A) ADHD predominantly inattentive 6\. \*\*Which of the following is a key difference in ADHD symptoms between childhood and adulthood?\*\* \- A) Adults experience more hyperactivity than inattention \- B) Hyperactivity dominates in childhood, while inattention dominates in adulthood \- C) Children only have inattention issues \- D) Adults do not experience any ADHD symptoms \*\*Answer\*\*: B) Hyperactivity dominates in childhood, while inattention dominates in adulthood \#\#\# Slide 3 - Nonpharmacologic Treatment 7\. \*\*Which nonpharmacologic treatment has been approved for children with ADHD?\*\* \- A) Cognitive Behavioral Therapy (CBT) \- B) Behavioral modification \- C) EndeavorRx, a game-based device \- D) Family therapy \*\*Answer\*\*: C) EndeavorRx, a game-based device 8\. \*\*Which treatment is beneficial for adults with ADHD but not as effective as stimulants?\*\* \- A) Behavioral modification \- B) Family education \- C) Cognitive Behavioral Therapy (CBT) \- D) EndeavorRx \*\*Answer\*\*: C) Cognitive Behavioral Therapy (CBT) 9\. \*\*What is a key component of ADHD nonpharmacologic treatment?\*\* \- A) Limiting physical activity \- B) Patient and family education \- C) Discontinuing stimulant medications \- D) No need for behavioral interventions \*\*Answer\*\*: B) Patient and family education \#\#\# Slide 4 - Stimulant Therapy 10\. \*\*What is the recommended first-line treatment for ADHD in children aged 6-18 years?\*\* \- A) Atomoxetine \- B) Guanfacine \- C) Stimulant medications \- D) Clonidine \*\*Answer\*\*: C) Stimulant medications 11\. \*\*What is the second-line treatment for ADHD if stimulants fail?\*\* \- A) Clonidine \- B) Atomoxetine \- C) Guanfacine \- D) Behavioral therapy \*\*Answer\*\*: B) Atomoxetine 12\. \*\*Which age group should begin ADHD treatment with behavioral therapy rather than medication?\*\* \- A) 4-5 years old \- B) 6-8 years old \- C) 9-12 years old \- D) 13-18 years old \*\*Answer\*\*: A) 4-5 years old \#\#\# Slide 5 - Stimulant Therapy: Drug Interactions 13\. \*\*Which class of drugs should not be used with stimulants due to the risk of hypertensive crisis?\*\* \- A) Antidepressants \- B) Monoamine oxidase inhibitors (MAOIs) \- C) Beta-blockers \- D) Antihistamines \*\*Answer\*\*: B) Monoamine oxidase inhibitors (MAOIs) 14\. \*\*What serious adverse effect can occur if methylphenidate is combined with clonidine?\*\* \- A) Seizures \- B) Increased cardiovascular effects \- C) Hypotension \- D) Increased risk of infection \*\*Answer\*\*: B) Increased cardiovascular effects 15\. \*\*What is the required washout period when switching between stimulants and MAOIs?\*\* \- A) 3 days \- B) 7 days \- C) 10 days \- D) 14 days \*\*Answer\*\*: D) 14 days \#\#\# Slide 6 - Atomoxetine 16\. \*\*What is the mechanism of action of atomoxetine (Strattera)?\*\* \- A) Inhibits dopamine reuptake \- B) Inhibits norepinephrine reuptake \- C) Inhibits serotonin reuptake \- D) Inhibits acetylcholine release \*\*Answer\*\*: B) Inhibits norepinephrine reuptake 17\. \*\*What is a potential adverse effect of atomoxetine?\*\* \- A) Hepatotoxicity \- B) Hyperactivity \- C) Weight gain \- D) Hyperglycemia \*\*Answer\*\*: A) Hepatotoxicity 18\. \*\*How long does it take for atomoxetine to reach full efficacy?\*\* \- A) 1-2 days \- B) 1 week \- C) 2 weeks \- D) 4 weeks \*\*Answer\*\*: D) 4 weeks Let me know if you\'d like additional questions from the remaining slides!